The Nike Mag, complete with “Adaptive Fit,” is now available in an effort to speed a cure for Parkinson’s disease.

Almost 30 years ago, Nike inspired a future vision of footwear — an individually responsive shoe that senses the wearer and adapts on its own. Famously worn on the silver screen by Michael J. Fox, the shoe quickly became a cultural icon. Today, Nike and The Michael J. Fox Foundation proudly announce the release of the 2016 Nike Mag — a limited-edition release of only 89 pairs available globally through an online draw — to once again channel the excitement of the Nike Mag to raise awareness in the fight against Parkinson’s and the Foundation’s tireless efforts to speed a cure.

How to get the Nike Mag

• The majority of these will be available to residents of the United States and Canada through a digital draw process. Entrance to The Draw is via nike.com/mag or via the Nike+ App, with each entry granting equal opportunity to win a pair of the Nike Mag. Tickets are $10 donations to The Michael J. Fox Foundation. There is no limit to the amount of tickets that can be obtained per individual — the more tickets, the greater chance of winning. The Draw will begin on October 4, 2016 and end October 11, 2016. Winners will be notified October 17, 2016.
• One pair of the Nike Mag will also be auctioned live in three places: Hong Kong on October 11, 2016; London on October 14 and 17; and in New York on November 12 at The Michael J. Fox Foundation’s benefit gala, “A Funny Thing Happened on the Way to Cure Parkinson’s.”
• 100 percent of the proceeds will go to The Michael J. Fox Foundation and drive critical research to accelerate development of a cure for Parkinson’s disease.

As the world’s largest nonprofit funder of Parkinson’s research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson’s disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson’s patients, business leaders, clinical trial participants, donors and volunteers.

In addition to funding more than $650 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson’s research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson’s disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson’s awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.